Northside Capital Management, LLC Gilead Sciences, Inc. Transaction History

Northside Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $269,900 - $306,342	-4,160 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $5,712 - $6,241	-90 Reduced 2.12%	4,160 $286,000
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $19,500 - $22,249	-325 Reduced 7.1%	4,250 $275,000
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $122,477 - $139,557	-2,162 Reduced 32.09%	4,575 $267,000
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $8,768 - $11,230	-140 Reduced 2.04%	6,737 $504,000

Q4 2019 Jan 09, 2020	SELL	$61.62 - $67.78 $45,290 - $49,818	-735 Reduced 9.66%	6,877 $447,000
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $4,813 - $5,313	77 Added 1.02%	7,612 $482,000
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $32,791 - $36,771	530 Added 7.57%	7,535 $509,000
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $13,197 - $17,222	218 Added 3.21%	7,005 $438,000
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $489,410 - $580,084	6,787	6,787 $550,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Northside Capital Management, LLC with notifications on news.